{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:55Z","timestamp":1791644455520,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10549-022-06601-8","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T14:03:13Z","timestamp":1650031393000},"page":"637-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis"],"prefix":"10.1007","volume":"193","author":[{"given":"Dooreh","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soong June","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Gwe","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goeun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-5781","authenticated-orcid":false,"given":"Chang Ik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"issue":"16","key":"6601_CR1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233\u20131241. https:\/\/doi.org\/10.1056\/NEJMoa022152","journal-title":"N Engl J Med"},{"issue":"2","key":"6601_CR2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","volume":"105","author":"CJ Ladbury","year":"2019","unstructured":"Ladbury CJ, Rusthoven CG, Camidge DR et al (2019) Impact of radiation dose to the host immune system on tumor control and survival for stage III non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 105(2):346\u2013355. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.05.064","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"6601_CR3","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/bcp.14351","volume":"86","author":"V Gomez","year":"2020","unstructured":"Gomez V, Mustapha R, Ng K et al (2020) Radiation therapy and the innate immune response: clinical implications for immunotherapy approaches. Br J Clin Pharmacol 86(9):1726\u20131735. https:\/\/doi.org\/10.1111\/bcp.14351","journal-title":"Br J Clin Pharmacol"},{"issue":"21","key":"6601_CR4","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1200\/JCO.2008.18.9068","volume":"27","author":"BL Pierce","year":"2009","unstructured":"Pierce BL, Ballard-Barbash R, Bernstein L et al (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27(21):3437\u20133444. https:\/\/doi.org\/10.1200\/JCO.2008.18.9068","journal-title":"J Clin Oncol"},{"issue":"7","key":"6601_CR5","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.3390\/cancers12071896","volume":"12","author":"CI Yoon","year":"2020","unstructured":"Yoon CI, Kim D, Ahn SG et al (2020) Radiotherapy-induced high neutrophil-to-lymphocyte ratio is a negative prognostic factor in patients with breast cancer. Cancers (Basel) 12(7):1896. https:\/\/doi.org\/10.3390\/cancers12071896","journal-title":"Cancers (Basel)"},{"issue":"6917","key":"6601_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860\u2013867. https:\/\/doi.org\/10.1038\/nature01322","journal-title":"Nature"},{"issue":"7203","key":"6601_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444. https:\/\/doi.org\/10.1038\/nature07205","journal-title":"Nature"},{"issue":"1","key":"6601_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1186\/s12885-019-6157-4","volume":"19","author":"KJ Li","year":"2019","unstructured":"Li KJ, Xia XF, Su M et al (2019) Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy. BMC Cancer 19(1):1004. https:\/\/doi.org\/10.1186\/s12885-019-6157-4","journal-title":"BMC Cancer"},{"key":"6601_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.radonc.2020.09.012","volume":"154","author":"CH Lin","year":"2021","unstructured":"Lin CH, Chou WC, Wu YY et al (2021) Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study. Radiother Oncol 154:76\u201386. https:\/\/doi.org\/10.1016\/j.radonc.2020.09.012","journal-title":"Radiother Oncol"},{"issue":"3","key":"6601_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JCY Chan","year":"2017","unstructured":"Chan JCY, Chan DL, Diakos CI et al (2017) The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg 265(3):539\u2013546. https:\/\/doi.org\/10.1097\/SLA.0000000000001743","journal-title":"Ann Surg"},{"issue":"1","key":"6601_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12957-020-01962-0","volume":"18","author":"S Lin","year":"2020","unstructured":"Lin S, Fang Y, Mo Z et al (2020) Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients. World Journal of Surgical Oncology 18(1):186. https:\/\/doi.org\/10.1186\/s12957-020-01962-0","journal-title":"World Journal of Surgical Oncology"},{"issue":"11","key":"6601_CR12","doi-asserted-by":"publisher","first-page":"e017904","DOI":"10.1136\/bmjopen-2017-017904","volume":"7","author":"SF Lee","year":"2017","unstructured":"Lee SF, Luque-Fernandez MA (2017) Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study. BMJ Open 7(11):e017904. https:\/\/doi.org\/10.1136\/bmjopen-2017-017904","journal-title":"BMJ Open"},{"issue":"1","key":"6601_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/cmr.0000000000000290","volume":"27","author":"AA Leontovich","year":"2017","unstructured":"Leontovich AA, Dronca RS, Nevala WK et al (2017) Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients. Melanoma Res 27(1):32\u201342. https:\/\/doi.org\/10.1097\/cmr.0000000000000290","journal-title":"Melanoma Res"},{"issue":"4","key":"6601_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12094-017-1732-0","volume":"20","author":"C Marin Hernandez","year":"2018","unstructured":"Marin Hernandez C, Pinero Madrona A, Gil Vazquez PJ et al (2018) Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy. Clin Transl Oncol 20(4):476\u2013483. https:\/\/doi.org\/10.1007\/s12094-017-1732-0","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"6601_CR15","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1186\/s12885-018-5051-9","volume":"18","author":"W Goto","year":"2018","unstructured":"Goto W, Kashiwagi S, Asano Y et al (2018) Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer. BMC Cancer 18(1):1137. https:\/\/doi.org\/10.1186\/s12885-018-5051-9","journal-title":"BMC Cancer"},{"key":"6601_CR16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2147\/cmar.S292048","volume":"13","author":"Y Ma","year":"2021","unstructured":"Ma Y, Zhang J, Chen X (2021) Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancer Manag Res 13:1571\u20131580. https:\/\/doi.org\/10.2147\/cmar.S292048","journal-title":"Cancer Manag Res"},{"issue":"2","key":"6601_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/bjc.2013.785","volume":"110","author":"M Stotz","year":"2014","unstructured":"Stotz M, Pichler M, Absenger G et al (2014) The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer 110(2):435\u2013440. https:\/\/doi.org\/10.1038\/bjc.2013.785","journal-title":"Br J Cancer"},{"issue":"suppl 1","key":"6601_CR18","first-page":"81","volume":"60","author":"A Castello","year":"2019","unstructured":"Castello A, Toschi L, Grizzi F et al (2019) Metabolic parameters by 18F-FDG PET\/CT and peripheral blood biomarkers are associated with outcomes in patients with NSCLC under immune checkpoint inhibitors treatment: the Immune-Metabolic-Prognostic Index (IMPI). J Nucl Med 60(suppl 1):81","journal-title":"J Nucl Med"},{"issue":"11","key":"6601_CR19","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1038\/sj.bjc.6601705","volume":"90","author":"EY Lin","year":"2004","unstructured":"Lin EY, Pollard JW (2004) Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90(11):2053\u20132058. https:\/\/doi.org\/10.1038\/sj.bjc.6601705","journal-title":"Br J Cancer"},{"issue":"8","key":"6601_CR20","first-page":"2553","volume":"8","author":"TK Hoffmann","year":"2002","unstructured":"Hoffmann TK, Dworacki G, Tsukihiro T et al (2002) Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8(8):2553\u20132562","journal-title":"Clin Cancer Res"},{"issue":"2","key":"6601_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","volume":"106","author":"CE Olingy","year":"2019","unstructured":"Olingy CE, Dinh HQ, Hedrick CC (2019) Monocyte heterogeneity and functions in cancer. J Leukoc Biol 106(2):309\u2013322. https:\/\/doi.org\/10.1002\/JLB.4RI0818-311R","journal-title":"J Leukoc Biol"},{"issue":"2","key":"6601_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.it.2020.12.001","volume":"42","author":"A Robinson","year":"2021","unstructured":"Robinson A, Han CZ, Glass CK et al (2021) Monocyte regulation in homeostasis and malignancy. Trends Immunol 42(2):104\u2013119. https:\/\/doi.org\/10.1016\/j.it.2020.12.001","journal-title":"Trends Immunol"},{"key":"6601_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijsu.2018.05.030","volume":"55","author":"D Tan","year":"2018","unstructured":"Tan D, Fu Y, Tong W et al (2018) Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: a meta-analysis. Int J Surg 55:128\u2013138. https:\/\/doi.org\/10.1016\/j.ijsu.2018.05.030","journal-title":"Int J Surg"},{"issue":"1","key":"6601_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32\u201335. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3c32::aid-cncr2820030106%3e3.0.co;2-3","journal-title":"Cancer"},{"issue":"6","key":"6601_CR25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/sim.5992","volume":"33","author":"J Yin","year":"2014","unstructured":"Yin J, Tian L (2014) Joint confidence region estimation for area under ROC curve and Youden index. Stat Med 33(6):985\u20131000. https:\/\/doi.org\/10.1002\/sim.5992","journal-title":"Stat Med"},{"key":"6601_CR26","volume-title":"Classification and regression trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman J, Stone CJ et al (1984) Classification and regression trees. CRC Press"},{"issue":"1","key":"6601_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13048-019-0527-z","volume":"12","author":"J Gong","year":"2019","unstructured":"Gong J, Jiang H, Shu C et al (2019) Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis. J Ovarian Res 12(1):51. https:\/\/doi.org\/10.1186\/s13048-019-0527-z","journal-title":"J Ovarian Res"},{"issue":"1","key":"6601_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijrobp.2020.02.633","volume":"108","author":"G-Y Sun","year":"2020","unstructured":"Sun G-Y, Wang S-L, Song Y-W et al (2020) Radiation-induced lymphopenia predicts poorer prognosis in patients with breast cancer: a post hoc analysis of a randomized controlled trial of postmastectomy hypofractionated radiation therapy. Int J Radiat Oncol Biol Phys 108(1):277\u2013285. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.02.633","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"6601_CR29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.21037\/atm-21-2150","volume":"9","author":"F Chen","year":"2021","unstructured":"Chen F, Yu H, Zhang H et al (2021) Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy. Ann Transl Med 9(16):1288. https:\/\/doi.org\/10.21037\/atm-21-2150","journal-title":"Ann Transl Med"},{"issue":"2","key":"6601_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semradonc.2019.12.003","volume":"30","author":"P Lambin","year":"2020","unstructured":"Lambin P, Lieverse RIY, Eckert F et al (2020) Lymphocyte-sparing radiotherapy: the rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy. Semin Radiat Oncol 30(2):187\u2013193. https:\/\/doi.org\/10.1016\/j.semradonc.2019.12.003","journal-title":"Semin Radiat Oncol"},{"issue":"24","key":"6601_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014834","volume":"98","author":"C Kumarasamy","year":"2019","unstructured":"Kumarasamy C, Sabarimurugan S, Madurantakam RM et al (2019) Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-a protocol for systematic review and meta-analysis. Medicine (Baltimore) 98(24):e14834. https:\/\/doi.org\/10.1097\/MD.0000000000014834","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"6601_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/07357907.2012.762780","volume":"31","author":"S Yovino","year":"2013","unstructured":"Yovino S, Kleinberg L, Grossman SA et al (2013) The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest 31(2):140\u2013144. https:\/\/doi.org\/10.3109\/07357907.2012.762780","journal-title":"Cancer Invest"},{"issue":"5","key":"6601_CR33","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0360-3016(85)90114-2","volume":"11","author":"S Rotstein","year":"1985","unstructured":"Rotstein S, Blomgren H, Petrini B et al (1985) Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population. Int J Radiat Oncol Biol Phys 11(5):921\u2013925. https:\/\/doi.org\/10.1016\/0360-3016(85)90114-2","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6601_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197603)37:3<1417::AID-CNCR2820370324>3.0.CO;2-NJournalName:Cancer,37(3),pp.1417-1421;OtherInformation:Orig.ReceiptDate:30-JUN-76","author":"M Raben","year":"1976","unstructured":"Raben M, Walach N, Galili U et al (1976). Effect of radiation therapy on lymphocyte subpopulations in cancer patients. https:\/\/doi.org\/10.1002\/1097-0142(197603)37:3%3c1417::AID-CNCR2820370324%3e3.0.CO;2-NJournalName:Cancer,37(3),pp.1417-1421;OtherInformation:Orig.ReceiptDate:30-JUN-76","journal-title":"Effect of radiation therapy on lymphocyte subpopulations in cancer patients"},{"issue":"1","key":"6601_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","volume":"7","author":"C M\u00e9n\u00e9trier-Caux","year":"2019","unstructured":"M\u00e9n\u00e9trier-Caux C, Ray-Coquard I, Blay J-Y et al (2019) Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines? J Immunother Cancer 7(1):85. https:\/\/doi.org\/10.1186\/s40425-019-0549-5","journal-title":"J Immunother Cancer"},{"issue":"1","key":"6601_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41(1):49\u201361. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.010","journal-title":"Immunity"},{"issue":"1","key":"6601_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39\u201351. https:\/\/doi.org\/10.1016\/j.cell.2010.03.014","journal-title":"Cell"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06601-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06601-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06601-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T13:17:37Z","timestamp":1652793457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06601-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6601"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06601-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Patient consent was waived due to the retrospective study design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}}]}}